Clearstead Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Buy |
923
+790
| +594% | +$303K | 0.01% | 704 |
|
|
2025
Q1 | $46K | Sell |
133
-551
| -81% | -$190K | ﹤0.01% | 1190 |
|
|
2024
Q4 | $205K | Buy |
684
+264
| +63% | +$79.2K | ﹤0.01% | 848 |
|
|
2024
Q3 | $171K | Buy |
420
+39
| +10% | +$15.9K | ﹤0.01% | 901 |
|
|
2024
Q2 | $122K | Buy |
381
+208
| +120% | +$66.8K | ﹤0.01% | 951 |
|
|
2024
Q1 | $54.9K | Buy |
173
+37
| +27% | +$11.7K | ﹤0.01% | 739 |
|
|
2023
Q4 | $36.8K | Sell |
136
-66
| -33% | -$17.9K | ﹤0.01% | 812 |
|
|
2023
Q3 | $49.7K | Buy |
202
+112
| +124% | +$27.6K | ﹤0.01% | 882 |
|
|
2023
Q2 | $27.3K | Sell |
90
-4
| -4% | -$1.21K | ﹤0.01% | 846 |
|
|
2023
Q1 | $24.8K | Buy |
94
+22
| +31% | +$5.8K | ﹤0.01% | 807 |
|
|
2022
Q4 | $17.3K | Hold |
72
| – | – | ﹤0.01% | 822 |
|
|
2022
Q3 | $13K | Buy |
72
+20
| +38% | +$3.61K | ﹤0.01% | 843 |
|
|
2022
Q2 | $9K | Buy |
52
+33
| +174% | +$5.71K | ﹤0.01% | 930 |
|
|
2022
Q1 | $5K | Hold |
19
| – | – | ﹤0.01% | 1074 |
|
|
2021
Q4 | $5K | Hold |
19
| – | – | ﹤0.01% | 995 |
|
|
2021
Q3 | $5K | Sell |
19
-14
| -42% | -$3.68K | ﹤0.01% | 1018 |
|
|
2021
Q2 | $7K | Buy |
33
+14
| +74% | +$2.97K | ﹤0.01% | 838 |
|
|
2021
Q1 | $4K | Hold |
19
| – | – | ﹤0.01% | 888 |
|
|
2020
Q4 | $3K | Hold |
19
| – | – | ﹤0.01% | 849 |
|
|
2020
Q3 | $2K | Hold |
19
| – | – | ﹤0.01% | 816 |
|
|
2020
Q2 | $2K | Hold |
19
| – | – | ﹤0.01% | 740 |
|
|
2020
Q1 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 723 |
|